Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy.
Weber J, Rangel HR, Chakraborty B, Tadele M, Martinez MA, Martinez-Picado J, Marotta ML, Mirza M, Ruiz L, Clotet B, Wrin T, Petropoulos CJ, Quiñones-Mateu ME. Weber J, et al. Among authors: rangel hr. J Gen Virol. 2003 Aug;84(Pt 8):2217-2228. doi: 10.1099/vir.0.19123-0. J Gen Virol. 2003. PMID: 12867654
Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.
Quiñones-Mateu ME, Tadele M, Parera M, Mas A, Weber J, Rangel HR, Chakraborty B, Clotet B, Domingo E, Menéndez-Arias L, Martínez MA. Quiñones-Mateu ME, et al. Among authors: rangel hr. J Virol. 2002 Oct;76(20):10546-52. doi: 10.1128/jvi.76.20.10546-10552.2002. J Virol. 2002. PMID: 12239335 Free PMC article.
Role of Baseline pol Genotype in HIV-1 Fitness Evolution.
Weber J, Rangel HR, Chakraborty B, Marotta ML, Valdez H, Fransen K, Florence E, Connick E, Smith KY, Colebunders RL, Landay A, Kuritzkes DR, Lederman MM, Vanham G, Quiñones-Mateu ME. Weber J, et al. Among authors: rangel hr. J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):448-60. doi: 10.1097/00126334-200308010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12869833 Clinical Trial.
Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication.
Quiñones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, Marotta ML, Mirza M, Jiang B, Kiser P, Medvik K, Sieg SF, Weinberg A. Quiñones-Mateu ME, et al. Among authors: rangel hr. AIDS. 2003 Nov 7;17(16):F39-48. doi: 10.1097/00002030-200311070-00001. AIDS. 2003. PMID: 14571200
Can HIV-1 superinfection compromise antiretroviral therapy?
Chakraborty B, Kiser P, Rangel HR, Weber J, Mirza M, Marotta ML, Asaad R, Rodriguez B, Valdez H, Lederman MM, Quiñones-Mateu ME. Chakraborty B, et al. Among authors: rangel hr. AIDS. 2004 Jan 2;18(1):132-4. doi: 10.1097/00002030-200401020-00019. AIDS. 2004. PMID: 15090842 No abstract available.
50 results